Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice

Neurology

Volumn 50, Issue 1, 1998, Pages 106-113

  Vig, P J S ^a   Subramony, S H ^a   Burright, E N ^b   Fratkin, J D ^a   McDaniel, D O ^a   Desaiah, D ^a   Qin, Z ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; PARVALBUMIN;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CEREBELLAR ATAXIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MEMBRANE DEPOLARIZATION; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; SECOND MESSENGER; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 0031883824     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.1.106     Document Type: Article

References (48)

1. Baimbridge KG, Celio MR, Rogers JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992;15:303-308.
2. Kennedy MB. Regulation of neuronal function by calcium. Trends Neurosci 1989;12:417-419.
3. Cheung WY. Calmodulin. Sci Am 1982;246:62-70.
4. Heizmann CW, Hunziker W. Intracellular calcium-binding proteins: more sites than insights. Trends Biochem Sci 1991; 16:98-103.
5. 2+-binding proteins in normal and tumor cells: a topical review. Cell Calcium 1987;8:1-41.
6. Helzmann CW, Celio MR. Immunolocalization of parvalbumin. Methods Enzymol 1987;139:552-570.
7. Meittinen M, Kovisto E, Riekkinen P, Miettinen R. Coexistence of parvalbumin and GABA in nonpyramidal neurons of the rat entorhinal cortex. Brain Res 1996;706:113-122.
8. Satoh J, Tabira T, Sano M, Nakayama H, Tateishi J. Parvalbumin immunoreactive neurons in human central nervous system are decreased in Alzheimer's disease. Acta Neuropathol (Berl) 1991;81:388-395.
9. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15:303-308.
10. Yamakuni T, Usui H, Iwanaga T, Kondo H, Odani S, Takahashi Y. Isolation and immunohistochemical localization of a cerebellar protein. Neurosci Lett 1984;45:235-240.
11. Cheema IR, Western L, Wadley AM. Effect of parvalbumin and S-100 protein on protein synthesis in rabbit reticulocyte lysate. Cytobios 1991;68:77-83.
12. Andressen C, Gotzos V, Berchtold MW, et al. Changes in shape and motility of cells transfected with parvalbumin cDNA. Exp Cell Res 1995;219:420-426.
13. 2+ after exposure to glutamate receptor agonist. Exp Brain Res 1988;73:447-458.
14. 2+ influx in cultured hippocampal neurons. Neuron 1990;2:105-117.
15. Mattson MP, Rychlik B, Chu C, Christakos S. Evidence for calcium-reducing and excitoprotective roles for the calcium binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 1991;6:41-51.
16. 2+-binding systems and neuronal aging. Ann NY Acad Sci 1989;568:89-94.
17. Maragos WP, Greenamyre JT, Penney Jr JB, Young AB. Glutamate dysfunction in Alzheimer's disease: an hypothesis. Trends Neurosci 1987;10:65-68.
18. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor. Trends Neurosci 1987;10:299-302.
19. Choi D. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-634.
20. Siman R, Noszek JC, Kegerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 1989;9:1579-1590.
21. Ho BK, Alexianu ME, Colom LV, Mohamed AH, Serrano F, Appel SH. Expression of calbindin-D28k in motoneuron hybrid cells after retroviral infection with calbindin-D28k cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Natl Acad Sci USA 1996;93:6796-6801.
22. Ishikawa K, Mizusawa H, Fujita T. Calbindin-D28k immunoreactivity in the cerebellum of spinocerebellar degeneration. J Neurol Sci 1995;129:179-185.
23. Vig PJS, Fratkin JD, Desaiah D, Currier RD, Subramony SH. Decreased parvalbumin immunoreactivity in surviving Purkinje's cells of patients with spinocerebellar ataxia-1. Neurology 1996;47:249-253.
24. Zhuchenko O, Bailey J, Bonncn P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat Genet 1997;15:62-69.
25. Zoghbi HY, Orr HT. Spinocerebellar ataxia type 1. Semin Cell Biol 1995;6:29-35.
26. Orr HT, Chung M-Y, Bonfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
27. Paulson HL, Fishbeck KH. Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 1996;19:79-107.
28. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers. Their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 1994;91:5355-5358.
29. Burright EN, Clark HB, Servadio A, et al. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 1995;82:937-948.
30. Winsky L, Kuznicki J. Distribution of calretinin, calbindin D28k, and parvalbumin in subcellular fractions of rat cerebellum: effect of calcium. J Neurochem 1995;65:381-388.
31. Winsky L, Kuznicki J. Antibody recognition of calcium-binding proteins depends on their calcium-binding status. J Neurochem 1996;66:764-770.
32. Johansen FF, Tonder N, Zimmer J, Baimbridge KG, Diemer NH. Short-term changes of parvalbumin and calbindin immunoreactivity in the rat hippocampus following cerebral ischemia. Neurosci Lett 1990;120:171-174.
33. 28k in hypothalamic neurons grown in serum-free medium. J Neurochem 1987;49:442-451.
34. Olive M, Ferrer I. Parvalbumin immunohistochemistry in denervated skeletal muscle. Neuropathol Appl Neurobiol 1994;20(5):495-500.
35. Sloviter RS, Sollas AL, Barbaro NM, Laxer DK. Calcium binding proteins calbindin (28k) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J Comp Neurol 1991;308:381-391.
36. Nishiyama E, Ohwade J, Iwamoto N, Arai H. Selective loss of calbindin D28k-immunoreactive neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study. Neurosci Lett 1993;163:223-226.
37. Iacopino AM, Christakos S. Specific reduction of calcium binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 1990;87:4078-4082.
38. Elliott J, Snider W. Differential gene expression in ALS-sensitive and ALS-resistant motor neurons [abstract]. Neurology 1995;45(suppl 4):305.
39. Airaksinen MS, Eilers J, Garaschuk O, Thoenen H, Konnerth R, Meyer M. Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of calbindin D28k gene. Proc Natl Acad Sci USA 1997;94:1488-1493.
40. 2+ signalling in fine dendrites and spines of cerebellar Purkinje neurons. Nature (London) 1995;373:155-158.
41. Eilers J, Schneggenburger R, Konneth A. Patch-clamp and calcium imaging in brain slices. In: Sakmann B, Neher E, eds. Single channel recordings. New York: Plenum, 1995:213-229.
42. Llinas R, Sugimori M. Electrophysiological properties of in vitro Purkinje cell dendrites in mammalian cerebellar slices. J Physiol 1980;305:197-213.
43. Hounsgaard J, Midtgaard J. Synaptic control of excitability in turtle cerebellar Purkinje cells. J Physiol 1989;409:157-170.
44. Kohr G, Lambert CE, Mody I. Calbindin-D28k (CaBP) levels and calcium currents in acutely dissociated epileptic neurons. Exp Brain Res 1991;85:543-551.
45. Konnerth A, Dreessen J, Augustine GJ. Brief dendritic calcium signals initiate long-lasting synaptic depression in cerebellar Purkinje cells. Proc Natl Acad Sci USA 1992;89: 7051-7055.
46. Kano M, Rexhausen U, Dreesen J, Konnerth A. Synaptic excitation produces a long-lasting rebound potentiation of inhibitory synaptic signals in cerebellar Purkinje cells. Nature (London) 1992;356:601-604.
47. Burright EN, Davidson JD, Duvick LA, Koshy B, Zoghbi HY, Orr HT. Identification of a self-association region within the SCA-1 gene product, ataxin-1. Hum Mol Genet 1997;6:513-518.
48. Koshy B, Matilla T, Burright EN, et al. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 1996;5:1311-1318.